1.1.
Beschaffer
Offizielle Bezeichnung: Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH
Rechtsform des Erwerbers: Von einer zentralen Regierungsbehörde kontrolliertes öffentliches Unternehmen
Tätigkeit des öffentlichen Auftraggebers: Allgemeine öffentliche Verwaltung
2.1.
Verfahren
Titel: Supporting Ghanaian pharmaceutical manufacturers
Beschreibung: Access to affordable and high-quality vaccines and medicines is fundamental to ensuring the well-being of any population. Today, Ghana imports 70 % of the pharmaceutical products and 100 % of the vaccines it needs. As in many African nations, this reliance on imported pharmaceutical products is straining both the economy and public health security. The COVID-19 pandemic underscored the vulnerabilities inherent in this dependency, highlighting the importance for self-reliance and resilient healthcare systems. Ghana is therefore embarking on an ambitious initiative aimed at enhancing local manufacturing capacities for vaccines and medicines to foster availability and accessibility. The pharmaceutical sector has also been identified as an anchor industry for Ghana's industrial transformation and the creation of decent jobs. On the one hand, Ghana"s pharmaceutical industry faces challenges such as cost-intensive procurement of primary products from abroad, a lack of product diversification, high financing costs and a lack of the necessary technologies, technical capacities and skilled workforce. On the other hand, market opportunities are growing and the industry has a strong basis to build on, such as a network of existing local manufacturers, international collaborations for technology transfer, supply, skills development and research, as well as an enabling policy framework. Ghana thus has the potential to become one of the regional vaccine and pharmaceutical manufacturing hubs in Africa. Building on this momentum, the European Union (EU) and the German Federal Ministry for Economic Cooperation and Development (BMZ) are co-financing the programme "Strengthening the Ghanaian Pharmaceutical Sector with a Focus on Vaccine Production" (PharmaVax Ghana) as part of the Team Europe Initiative (TEI) Manufacturing and Access to Vaccines, Medicines and Health Technologies (MAV+). GIZ is the implementing agency for this EUR33 million technical cooperation programme running from July 2024 to March 2028. The programme"s specific objective is to ensure that the public and private ecosystems of Ghana"s pharmaceutical industry contribute to more competitive local manufacturing of pharmaceutical products. Within this ecosystem approach, the programme works on strengthening key enablers for efficient and sustainable vaccine and pharmaceutical manufacturing in Ghana. In particular, it focuses on four key result areas (components): (1) Governance & Regulation: Enhancing the capacities of Ghanaian public actors to effectively govern, coordinate and regulate pharmaceutical and vaccine manufacturing (2) Skills Development: Institutionalising practice-oriented, gender-responsive skills development measures needed to grow pharmaceutical and vaccine production capacities in Ghana (3) Research & Development (R&D): Fostering Ghanaian research institutions" applied R&D capacities and industry partnerships to stimulate local innovation in pharmaceutical and vaccine development and manufacturing (4) Private Sector Development: Enabling Ghanaian pharmaceutical and vaccine manufacturers to comply with good practices, become attractive for international partnerships and grow their business Ghana"s Ministry of Finance (MoF) is the programme"s political partner, with the Ministry of Trade and Industry (MoTI) and the National Vaccine Institute (NVI) being the key Ghanaian implementing partners. The programme also works in collaboration with the Food and Drugs Authority (FDA), line ministries for health, education and sciences, Ghana"s pharmaceutical manufacturers, private sector associations as well as relevant research and training institutions and it will create linkages with other African, European and international initiatives, research institutions and companies. GIZ intends to contract a service provider for the implementation of four work packages within component 4 of the PharmaVax Ghana the programme.
Kennung des Verfahrens: ff617416-930d-4ba9-b5e5-64be94f69eab
Interne Kennung: 81314988
Verfahrensart: Verhandlungsverfahren mit vorheriger Veröffentlichung eines Aufrufs zum Wettbewerb/Verhandlungsverfahren
Das Verfahren wird beschleunigt: nein
2.1.1.
Zweck
Art des Auftrags: Dienstleistungen
Haupteinstufung (cpv): 85000000 Dienstleistungen des Gesundheits- und Sozialwesens
Zusätzliche Einstufung (cpv): 79000000 Dienstleistungen für Unternehmen: Recht, Marketing, Consulting, Einstellungen, Druck und Sicherheit
2.1.2.
Erfüllungsort
Land: Ghana
Ort im betreffenden Land
2.1.4.
Allgemeine Informationen
Zusätzliche Informationen: #Bekanntmachungs-ID: CXTRYY6YTKFTTBDM# All communication takes place in English via communication tool in the project area of the procurement portal.
Rechtsgrundlage:
Richtlinie 2014/24/EU
vgv -
5.1.
Los: LOT-0001
Titel: Supporting Ghanaian pharmaceutical manufacturers
Beschreibung: This assignment contributes to the overall objective of the PharmaVax Ghana programme to ensure that the public and private ecosystems of Ghana"s pharmaceutical industry contribute to more competitive local manufacturing of pharmaceutical products. Specifically, the assignment supports the achievement of the specific objectives and indicators related to component 4 on private sector development. Component 4 aims to strengthen local pharmaceutical and vaccine manufacturers" capacities with regard to international good practices in the area of manufacturing and market access, so they become more competitive, can expand their own market activities and become more attractive for cooperation with international players. The hypothesis is that compliance with international manufacturing standards and/or international business-to-business cooperation for technology transfer will increase the quality of the products, resulting in new sales markets and higher sales for Ghanaian manufacturers. Higher productivity and quality standards of local pharmaceutical manufacturers also make Ghana more attractive as a location for international investors. Key partners are the Ghanaian pharmaceutical manufacturers and their associations, the Pharmaceutical Manufacturers Association of Ghana (PMAG) and the Small-Scale Pharmaceutical Manufacturers Association of Ghana (SSPMAG). The contractor is responsible for the following four work packages and for achieving the corresponding milestones. These work packages fall under component 4 but there are strong links to the other components, as well as with further activities under component 4 implemented by GIZ staff or other contractors or financing recipients, such as activities to promote trade capacities of manufacturers, investment promotion activities or support to business associations. Across all work packages, the contractor must ensure that the beneficiaries, which are local for-profit companies, are selected through open and transparent processes. Work package A: Business development, new markets and local value chains Technical support to Ghanaian pharmaceutical manufacturers on business development is crucial to compete with often cheaper imported products. An unpredictable and fragmented pharmaceutical market on the African continent is another challenge to be addressed. To enable manufacturers to mature and diversify their business, enter new markets and reach economies of scale, holistic support along the value chain and strong coordination is needed. Business Development Services (BDS) provided by the contractor must as far as possible be provided through local resources in order to build rather than crowd-out local capacities and also be coordinated with local business associations to ensure coherence. Key areas include: 1. General concept for BDS 2. Financing and controlling 3. Marketing 4. Product development 5. Green production and transformation 6. Human Resources (HR) and diversity management 7. Digitalisation of business processes ("digital transformation") 8. Market analysis and market entry studies 9. Integration of local support industries into the pharmaceutical value chain Work package B: Partnerships, technology transfers, licensing and intellectual property management The contractor shall prepare Ghanaian manufacturers for international cooperation (including technology transfers) and ultimately facilitate the partnerships for pharmaceutical manufacturing. A particular focus should be on the vaccine manufacturers. Work package C: International standards and practices While Ghanaian manufacturers produce under local Good Manufacturing Practices (GMP) conditions and are regulated by the Ghanaian Food and Drugs Authority, there is still a need to improve and comply with international standards and practices (EU GMP, US current GMP, etc.). A proof of compliance with international standards and practices (Pharmaceutical Inspection Co-operation Scheme (PIC/S), World Health Organization prequalification) will enable local manufacturers to participate in international tenders (Global Fund, UNICEF, etc.), enter new and strictly regulated markets (EU, Asia) and increase their competitiveness. The contractor shall prepare Ghanaian manufacturers for compliance with international standards and practices and ultimately facilitate the assessment of compliance. A particular focus should be on the vaccine manufacturers. Work package D: Call for Proposals for small-scale manufacturers Together with SSPMAG, a competition will be launched to provide technical, material and financial support for innovative proposals from micro and small producers. The support should specifically address quality upgrade and product diversification and innovation of SSPMAG member companies. The proposals developed for the call for proposals could aim at developing of new formulations or product lines including technical support and training, procurement of required small-scale equipment, procurement of required reagents and raw materials, etc. The proposal could also target improved marketing of already approved products (awareness raising campaigns, etc). Another aspect of the proposal could be advice on upgrade and renovation of manufacturing facilities to meet Ghana Food and Drugs Authority requirements and improve quality-assured production. Further details are to be confirmed during the development of the call for proposals. Support to 10 projects with a duration of up to 24 months each is expected (number and duration to be confirmed during concept development). Incentives should be provided to ensure that women benefit equally as entrepreneurs.
Interne Kennung: 81314988
5.1.1.
Zweck
Art des Auftrags: Dienstleistungen
Haupteinstufung (cpv): 85000000 Dienstleistungen des Gesundheits- und Sozialwesens
Zusätzliche Einstufung (cpv): 79000000 Dienstleistungen für Unternehmen: Recht, Marketing, Consulting, Einstellungen, Druck und Sicherheit
Optionen:
Beschreibung der Optionen: GIZ may optionally commission contract amendments and/or increases based on the criteria in the tender documents to the successful bidder of this tender. For details, please see the terms of reference.
5.1.2.
Erfüllungsort
Land: Ghana
Ort im betreffenden Land
5.1.3.
Geschätzte Dauer
Laufzeit: 30 Monate
5.1.4.
Verlängerung
Maximale Verlängerungen: 2
Weitere Informationen zur Verlängerung: GIZ may optionally commission contract amendments and/or increases based on the criteria in the tender documents to the successful bidder of this tender. For details, please see the terms of reference.
5.1.6.
Allgemeine Informationen
Auftragsvergabeprojekt ganz oder teilweise aus EU-Mitteln finanziert
Die Beschaffung fällt unter das Übereinkommen über das öffentliche Beschaffungswesen: ja
Zusätzliche Informationen: The contracting authority reserves the right to purchase services consisting of the repetition of similar services entrusted to the undertaking to which the same contracting authority awarded an initial contract, provided that these services are in conformity with a basic project for which the initial contract was awarded. (see Sec. 14 para. 4 no. 9 Public Procurement Regulation).
5.1.7.
Strategische Auftragsvergabe
Ziel der strategischen Auftragsvergabe: Keine strategische Beschaffung
5.1.10.
Zuschlagskriterien
Kriterium:
Art: Preis
Bezeichnung: Price
Beschreibung: Consideration of the price through the valuation method "Bestangebots-Quotienten-Methode"
Kategorie des Gewicht-Zuschlagskriteriums: Gewichtung (Punkte, genau)
Zuschlagskriterium — Zahl: 30,00
Kriterium:
Art: Qualität
Bezeichnung: Total points achieved after technical evaluation (including minimum requirement)
Beschreibung: In order to determine the most economical bidder, the contracting authority enters the total number of points achieved after technical evaluation. Only bids with a technical evaluation of over 500 points are considered. Technical bids with fewer points are rejected as technically unsuitable.
Kategorie des Gewicht-Zuschlagskriteriums: Gewichtung (Punkte, genau)
Zuschlagskriterium — Zahl: 70,00
Kriterium:
Art: Qualität
Bezeichnung: Total points achieved after technical evaluation (including minimum requirement)
Beschreibung: In order to determine the most economical bidder, the contracting authority enters the total number of points achieved after technical evaluation. Only bids with a technical evaluation of over 500 points are considered. Technical bids with fewer points are rejected as technically unsuitable.
Kategorie des Schwellen-Zuschlagskriteriums: Mindestpunktzahl
Zuschlagskriterium — Zahl: 500,00
5.1.15.
Techniken
Rahmenvereinbarung:
Keine Rahmenvereinbarung
Informationen über das dynamische Beschaffungssystem:
Kein dynamisches Beschaffungssystem
Elektronische Auktion: nein
5.1.16.
Weitere Informationen, Schlichtung und Nachprüfung
Überprüfungsstelle: Vergabekammern des Bundes
Informationen über die Überprüfungsfristen: According to Article 160, Section 3 of the German Act Against Restraint of Competition (GWB), application for review is not permissible insofar as 1. the applicant has identified the claimed infringement of the procurement rules before submitting the application for review and has not submitted a complaint to the contracting authority within a period of 10 calendar days; the expiry of the period pursuant to Article 134, Section 2 remains unaffected, 2. complaints of infringements of procurement rules that are evident in the tender notice are not submitted to the contracting authority at the latest by the expiry of the deadline for the application or by the deadline for the submission of bids, specified in the tender notice. 3. complaints of infringements of procurement rules that first become evident in the tender documents are not submitted to the contracting authority at the latest by the expiry of the deadline for application or by the deadline for the submission of bids, 4. more than 15 calendar days have expired since receipt of notification from the contracting authority that it is unwilling to redress the complaint. Sentence 1 does not apply in the case of an application to determine the invalidity of the contract in accordance with Article 135, Section 1 (2). Article 134, Section 1, Sentence 2 remains unaffected.
Organisation, die zusätzliche Informationen über das Vergabeverfahren bereitstellt: Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH
Wert aller in dieser Bekanntmachung vergebenen Verträge: 3 153 201,40 EUR
6.1.
Ergebnis, Los-– Kennung: LOT-0001
Status der Preisträgerauswahl: Es wurde mindestens ein Gewinner ermittelt.
6.1.2.
Informationen über die Gewinner
Wettbewerbsgewinner:
Offizielle Bezeichnung: Luvent Consulting GmbH
Angebot:
Kennung des Angebots: 4 - 83095
Kennung des Loses oder der Gruppe von Losen: LOT-0001
Wert der Ausschreibung: 3 153 201,40 EUR
Konzession – Wert:
Bei dem Angebot handelt es sich um eine Variante: nein
Vergabe von Unteraufträgen: Noch nicht bekannt
Informationen zum Auftrag:
Kennung des Auftrags: 1
Titel: Luvent Consulting GmbH
Datum des Vertragsabschlusses: 29/09/2025
6.1.4.
Statistische Informationen:
Eingegangene Angebote oder Teilnahmeanträge:
Art der eingegangenen Einreichungen: Angebote
Anzahl der eingegangenen Angebote oder Teilnahmeanträge: 4
Art der eingegangenen Einreichungen: Angebote auf elektronischem Wege eingereicht
Anzahl der eingegangenen Angebote oder Teilnahmeanträge: 4
Art der eingegangenen Einreichungen: Teilnahmeanträge
Anzahl der eingegangenen Angebote oder Teilnahmeanträge: 4
Art der eingegangenen Einreichungen: Angebote von Bietern, die in anderen Ländern des Europäischen Wirtschaftsraums registriert sind als dem Land des Beschaffers
Anzahl der eingegangenen Angebote oder Teilnahmeanträge: 0
Art der eingegangenen Einreichungen: Angebote von Bieter aus Ländern außerhalb des Europäischen Wirtschaftsraums
Anzahl der eingegangenen Angebote oder Teilnahmeanträge: 0
Art der eingegangenen Einreichungen: Angebote geprüft und als unzulässig abgewiesen
Anzahl der eingegangenen Angebote oder Teilnahmeanträge: 0
Art der eingegangenen Einreichungen: Angebote geprüft und aufgrund eines ungewöhnlich niedrigen Preises oder aufgrund ungewöhnlich niedriger Kosten als unzulässig abgewiesen
Anzahl der eingegangenen Angebote oder Teilnahmeanträge: 0
Bandbreite der Angebote:
Wert des niedrigsten zulässigen Angebots: 3 153 201,40 EUR
Wert des höchsten zulässigen Angebots: 4 099 225,00 EUR
8.1.
ORG-0001
Offizielle Bezeichnung: Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH
Registrierungsnummer: 993-80072-52
Postanschrift: Dag-Hammarskjöld-Weg 1 - 5
Stadt: Eschborn
Postleitzahl: 65760
Land, Gliederung (NUTS): Main-Taunus-Kreis (DE71A)
Land: Deutschland
Kontaktperson: Friedrich Graf von Westphalen & Partner mbB Rechtsanwälte
Telefon: +49 69719189012
Rollen dieser Organisation:
Beschaffer
Organisation, die zusätzliche Informationen über das Vergabeverfahren bereitstellt
8.1.
ORG-0002
Offizielle Bezeichnung: Vergabekammern des Bundes
Registrierungsnummer: 022894990
Postanschrift: Kaiser-Friedrich-Straße 16
Stadt: Bonn
Postleitzahl: 53113
Land, Gliederung (NUTS): Bonn, Kreisfreie Stadt (DEA22)
Land: Deutschland
Telefon: +49 2289499-0
Fax: +49 2289499-163
Rollen dieser Organisation:
Überprüfungsstelle
8.1.
ORG-0003
Offizielle Bezeichnung: Luvent Consulting GmbH
Größe des Wirtschaftsteilnehmers: Kleines Unternehmen
Registrierungsnummer: HRB 186246 B
Postanschrift: Raabestr. 8
Stadt: Berlin
Postleitzahl: 10405
Land, Gliederung (NUTS): Berlin (DE300)
Land: Deutschland
Telefon: +49 30 12086209
Rollen dieser Organisation:
Bieter
Wirtschaftlicher Eigentümer:
Staatsangehörigkeit des Eigentümers: Deutschland
Gewinner dieser Lose: LOT-0001
8.1.
ORG-0004
Offizielle Bezeichnung: Datenservice Öffentlicher Einkauf (in Verantwortung des Beschaffungsamts des BMI)
Registrierungsnummer: 0204:994-DOEVD-83
Stadt: Bonn
Postleitzahl: 53119
Land, Gliederung (NUTS): Bonn, Kreisfreie Stadt (DEA22)
Land: Deutschland
Telefon: +49228996100
Rollen dieser Organisation:
TED eSender
Kennung/Fassung der Bekanntmachung: 2e7f7548-0694-4625-be31-fa995e9be411 - 01
Formulartyp: Ergebnis
Art der Bekanntmachung: Bekanntmachung vergebener Aufträge oder Zuschlagsbekanntmachung – Standardregelung
Unterart der Bekanntmachung: 29
Datum der Übermittlung der Bekanntmachung: 11/10/2025 22:21:28 (UTC+2) Osteuropäische Zeit, Mitteleuropäische Sommerzeit
Sprachen, in denen diese Bekanntmachung offiziell verfügbar ist: Deutsch
Veröffentlichungsnummer der Bekanntmachung: 673979-2025
ABl. S – Nummer der Ausgabe: 197/2025
Datum der Veröffentlichung: 14/10/2025